Explore the vast range of titles available.

The performance of perovskite photovoltaics is fundamentally impeded by the presence of undesirable defects that contribute to non-radiative losses within the devices. Although mitigating these losses has been extensively reported by numerous passivation strategies, a detailed understanding of loss origins within the devices remains elusive. Here, we demonstrate that the defect capturing probability estimated by the capture cross-section is decreased by varying the dielectric response, producing the dielectric screening effect in the perovskite. The resulting perovskites also show reduced surface recombination and a weaker electron-phonon coupling. All of these boost the power conversion efficiency to 22.3% for an inverted perovskite photovoltaic device with a high open-circuit voltage of 1.25 V and a low voltage deficit of 0.37 V (a bandgap ~1.62 eV). Our results provide not only an in-depth understanding of the carrier capture processes in perovskites, but also a promising pathway for realizing highly efficient devices via dielectric regulation. Performance of perovskite photovoltaics is greatly affected by undesirable defects that contribute to non-radiative losses. Here, the authors mitigate these losses by doping perovskite with KI to alter the dielectric response, thus defect capturing probability, resulting in inverted device with PCE of 22.3% and low voltage loss.

Inverted planar perovskite solar cells offer opportunities for a simplified device structure compared with conventional mesoporous titanium oxide interlayers. However, their lower open-circuit voltages result in lower power conversion efficiencies. Using mixed-cation lead mixed-halide perovskite and a solution-processed secondary growth method, Luo et al. created a surface region in the perovskite film that inhibited nonradiative charge-carrier recombination. This kind of solar cell had comparable performance to that of conventional cells. Science , this issue p. 1442 High open-circuit voltages were achieved for planar perovskite solar cells by creating a graded junction. The highest power conversion efficiencies (PCEs) reported for perovskite solar cells (PSCs) with inverted planar structures are still inferior to those of PSCs with regular structures, mainly because of lower open-circuit voltages ( V oc ). Here we report a strategy to reduce nonradiative recombination for the inverted devices, based on a simple solution-processed secondary growth technique. This approach produces a wider bandgap top layer and a more n-type perovskite film, which mitigates nonradiative recombination, leading to an increase in V oc by up to 100 millivolts. We achieved a high V oc of 1.21 volts without sacrificing photocurrent, corresponding to a voltage deficit of 0.41 volts at a bandgap of 1.62 electron volts. This improvement led to a stabilized power output approaching 21% at the maximum power point.

Nesfatin‐1 (encoded by NUCB2) is a cardiac peptide possessing protective activities against myocardial ischaemia/reperfusion (MI/R) injury. However, the regulation of NUCB2/nesfatin‐1 and the molecular mechanisms underlying its roles in MI/R injury are not clear. Here, by investigating a mouse MI/R injury model developed with transient myocardial ischaemia followed by reperfusion, we found that the levels of NUCB2 transcript and nesfatin‐1 amount in the heart were both decreased, suggesting a transcriptional repression of NUCB2/nesfatin‐1 in response to MI/R injury. Moreover, cardiac nesfatin‐1 restoration reduced infarct size, troponin T (cTnT) level and myocardial apoptosis, supporting its cardioprotection against MI/R injury in vivo. Mechanistically, the Akt/ERK pathway was activated, and in contrast, endoplasmic reticulum (ER) stress was attenuated by nesfatin‐1 following MI/R injury. In an in vitro system, similar results were obtained in nesfatin‐1‐treated H9c2 cardiomyocytes with hypoxia/reoxygenation (H/R) injury. More importantly, the treatment of wortmannin, an inhibitor of Akt/ERK pathway, abrogated nesfatin‐1 effects on attenuating ER stress and H/R injury in H9c2 cells. Furthermore, nesfatin‐1‐mediated protection against H/R injury also vanished in the presence of tunicamycin (TM), an ER stress inducer. Lastly, Akt/ERK inhibition reversed nesfatin‐1 effects on mouse ER stress and MI/R injury in vivo. Taken together, these findings demonstrate that NUCB2/nesfatin‐1 inhibits MI/R injury through attenuating ER stress, which relies on Akt/ERK pathway activation. Hence, our study provides a molecular basis for understanding how NUCB2/nesfatin‐1 reduces MI/R injury.

Background Drug repositioning is a very important task that provides critical information for exploring the potential efficacy of drugs. Yet developing computational models that can effectively predict drug–disease associations (DDAs) is still a challenging task. Previous studies suggest that the accuracy of DDA prediction can be improved by integrating different types of biological features. But how to conduct an effective integration remains a challenging problem for accurately discovering new indications for approved drugs. Methods In this paper, we propose a novel meta-path based graph representation learning model, namely RLFDDA, to predict potential DDAs on heterogeneous biological networks. RLFDDA first calculates drug–drug similarities and disease–disease similarities as the intrinsic biological features of drugs and diseases. A heterogeneous network is then constructed by integrating DDAs, disease–protein associations and drug–protein associations. With such a network, RLFDDA adopts a meta-path random walk model to learn the latent representations of drugs and diseases, which are concatenated to construct joint representations of drug–disease associations. As the last step, we employ the random forest classifier to predict potential DDAs with their joint representations. Results To demonstrate the effectiveness of RLFDDA, we have conducted a series of experiments on two benchmark datasets by following a ten-fold cross-validation scheme. The results show that RLFDDA yields the best performance in terms of AUC and F1-score when compared with several state-of-the-art DDAs prediction models. We have also conducted a case study on two common diseases, i.e., paclitaxel and lung tumors, and found that 7 out of top-10 diseases and 8 out of top-10 drugs have already been validated for paclitaxel and lung tumors respectively with literature evidence. Hence, the promising performance of RLFDDA may provide a new perspective for novel DDAs discovery over heterogeneous networks.

Lead-halide perovskites are generally excellent light emitters and can have larger exciton binding energies than thermal energy at room temperature, exhibiting great promise for room-temperature exciton-polaritonics. Rapid progress has been made recently, although challenges and mysteries remain in lead-halide perovskite semiconductors to push polaritons to room-temperature operation. In this Perspective, we discuss fundamental aspects of perovskite semiconductors for exciton-polaritons and review the recent rapid experimental advances using lead-halide perovskites for room-temperature polaritonics, including the experimental realization of strong light–matter interaction using various types of microcavities as well as reaching the polariton condensation regime in planar microcavities and lattices. An outlook on the potential of lead-halide perovskites as a playground for exciton-polariton studies and for the development of polaritonic devices operating at room temperature is provided.

Exciton polaritons, with extremely low effective mass 1 , are regarded as promising candidates to realize Bose–Einstein condensation in lattices for quantum simulations 2 towards room-temperature operations 3 – 8 . Along with the condensation, an efficient exciton polariton quantum simulator 9 would require a strong lattice with robust polariton trapping as well as strong intersite coupling to allow coherent quantum motion of polaritons within the lattice. A strong lattice can be characterized with a larger forbidden bandgap opening and a larger lattice bandwidth compared with the linewidth. However, exciton polaritons in such strong lattices have only been shown to condense at cryogenic temperatures 3 – 8 . Here, we report the observation of non-equilibrium exciton polariton condensation in a one-dimensional strong lead halide perovskite lattice at room temperature. Modulated by deep periodic potentials, the strong lead halide perovskite lattice exhibits a large forbidden bandgap opening up to 13.3 meV and a lattice band up to 8.5 meV wide, which are at least 10 times larger than previous systems. Above a critical density, we observe polariton condensation into p y orbital states with long-range spatial coherence at room temperature. Our result opens the route to the implementation of polariton condensates in quantum simulators at room temperature. Non-equilibrium Bose–Einstein condensation of exciton polaritons in chains of lead halide perovskite pillars can occur at room temperature. These condensates have long spatial coherence.

Functional studies of the RNA N 6 -methyladenosine (m 6 A) modification have been limited by an inability to map individual m 6 A-modified sites in whole transcriptomes. To enable such studies, here, we introduce m 6 A-selective allyl chemical labeling and sequencing (m 6 A-SAC-seq), a method for quantitative, whole-transcriptome mapping of m 6 A at single-nucleotide resolution. The method requires only ~30 ng of poly(A) or rRNA-depleted RNA. We mapped m 6 A modification stoichiometries in RNA from cell lines and during in vitro monocytopoiesis from human hematopoietic stem and progenitor cells (HSPCs). We identified numerous cell-state-specific m 6 A sites whose methylation status was highly dynamic during cell differentiation. We observed changes of m 6 A stoichiometry as well as expression levels of transcripts encoding or regulated by key transcriptional factors (TFs) critical for HSPC differentiation. m 6 A-SAC-seq is a quantitative method to dissect the dynamics and functional roles of m 6 A sites in diverse biological processes using limited input RNA. m 6 A-SAC-seq uses chemical labeling to quantify m 6 A at single-base resolution in the mammalian transcriptome.

Tuning the composition of perovskites to approach the ideal bandgap raises the single-junction Shockley-Queisser efficiency limit of solar cells. The rapid development of narrow-bandgap formamidinium lead triiodide-based perovskites has brought perovskite single-junction solar cell efficiencies up to 26.1%. However, such compositional engineering route has reached the limit of the Goldschmidt tolerance factor. Here, we experimentally demonstrate a resonant perovskite solar cell that produces giant light absorption at the perovskite band edge with tiny absorption coefficients. We design multiple guide-mode resonances by momentum matching of waveguided modes and free-space light via Brillouin-zone folding, thus achieving an 18-nm band edge extension and 1.5 mA/cm 2 improvement of the current. The external quantum efficiency spectrum reaches a plateau of above 93% across the spectral range of ~500 to 800 nm. This resonant nanophotonics strategy translates to a maximum EQE-integrated current of 26.0 mA/cm 2 which is comparable to that of the champion single-crystal perovskite solar cell with a thickness of ~20 μm. Our findings break the ray-optics limit and open a new door to improve the efficiency of single-junction perovskite solar cells further when compositional engineering or other carrier managements are close to their limits. Further extending the band edge of perovskite approaching the ideal bandgap of single-junction solar cell is essential to improve device efficiency. Here, the authors integrate optical resonances with perovskite solar cells to extend the band edge, achieving EQE-integrated current of 26.0 mA/cm 2 .

Topologically nontrivial systems can be protected by band topology in momentum space, as seen in topological insulators and semimetals, or real-space topology, such as in lattice deformations known as topological disclinations (TDs). TDs, with inherent chiral symmetry, can support localized states pinned spectrally to the middle of the topological gap, preventing hybridization with bulk bands, and making them promising for topological lasers. Here, we experimentally realize a C 4 v symmetric TD laser based on perovskite exciton-polariton lattices at room temperature. Protected by the chiral and point group symmetries of the lattice, the TD state emerges in the middle of the gap and at the core of the perovskite lattice. Under a non-resonant pulsed excitation, coherent polariton lasing occurs precisely at the TD state with a low threshold of 9.5 μJ/cm 2 , as confirmed by momentum space and real space spectra measurements. This study not only introduces a class of symmetry-protected topological lasers, but also expands the landscape for exploring exciton-polariton light-matter interactions with novel topological structures. Topological lasers with enhanced robustness have revolutionized the paradigm of laser design, yet their implementation in disclination geometries remains largely unexplored. Here, the authors demonstrate a mid-gap topological exciton-polariton laser in a C 4 v disclination perovskite lattice at room temperature.